149 related articles for article (PubMed ID: 34870316)
1. Two cell line models to study multiorganic metastasis and immunotherapy in lung squamous cell carcinoma.
Valencia K; Sainz C; Bértolo C; de Biurrun G; Agorreta J; Azpilikueta A; Larrayoz M; Bosco G; Zandueta C; Redrado M; Redín E; Exposito F; Serrano D; Echepare M; Ajona D; Melero I; Pio R; Thomas R; Calvo A; Montuenga LM
Dis Model Mech; 2022 Jan; 15(1):. PubMed ID: 34870316
[TBL] [Abstract][Full Text] [Related]
2.
Succony L; Gómez-López S; Pennycuick A; Alhendi ASN; Davies D; Clarke SE; Gowers KHC; Wright NA; Jensen KB; Janes SM
Eur Respir J; 2022 Mar; 59(3):. PubMed ID: 34385275
[TBL] [Abstract][Full Text] [Related]
3. Successful Immunotherapy against a Transplantable Mouse Squamous Lung Carcinoma with Anti-PD-1 and Anti-CD137 Monoclonal Antibodies.
Azpilikueta A; Agorreta J; Labiano S; Pérez-Gracia JL; Sánchez-Paulete AR; Aznar MA; Ajona D; Gil-Bazo I; Larrayoz M; Teijeira A; Rodriguez-Ruiz ME; Pio R; Montuenga LM; Melero I
J Thorac Oncol; 2016 Apr; 11(4):524-36. PubMed ID: 26845193
[TBL] [Abstract][Full Text] [Related]
4. Role of deltaNp63(pos)CD44v(pos) cells in the development of N-nitroso-tris-chloroethylurea-induced peripheral-type mouse lung squamous cell carcinomas.
Yamano S; Gi M; Tago Y; Doi K; Okada S; Hirayama Y; Tachibana H; Ishii N; Fujioka M; Tatsumi K; Wanibuchi H
Cancer Sci; 2016 Feb; 107(2):123-32. PubMed ID: 26663681
[TBL] [Abstract][Full Text] [Related]
5. Epigenomic Profiling Discovers Trans-lineage SOX2 Partnerships Driving Tumor Heterogeneity in Lung Squamous Cell Carcinoma.
Sato T; Yoo S; Kong R; Sinha A; Chandramani-Shivalingappa P; Patel A; Fridrikh M; Nagano O; Masuko T; Beasley MB; Powell CA; Zhu J; Watanabe H
Cancer Res; 2019 Dec; 79(24):6084-6100. PubMed ID: 31551362
[TBL] [Abstract][Full Text] [Related]
6. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Li N; Li Y; Zheng P; Zhan X
Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in preclinical models for lung squamous cell carcinoma.
Pan Y; Han H; Labbe KE; Zhang H; Wong KK
Oncogene; 2021 Apr; 40(16):2817-2829. PubMed ID: 33707749
[TBL] [Abstract][Full Text] [Related]
8. MIR205HG facilitates carcinogenesis of lung squamous cell carcinoma in vitro revealed by long noncoding RNA profiling.
Chang Y; Xue X; Li C; Zhao W; Ma Y; Xu F; Wu Z; Dai Y; Li Y; Liu Y; Chen L
Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):371-381. PubMed ID: 32188965
[TBL] [Abstract][Full Text] [Related]
9. Role of downregulated ADARB1 in lung squamous cell carcinoma.
Wang X; Ren X; Liu W; Chen X; Wei J; Gong Z; Yan Y; Xu Z
Mol Med Rep; 2020 Mar; 21(3):1517-1526. PubMed ID: 32016472
[TBL] [Abstract][Full Text] [Related]
10. Construction and Validation of Prognostic Regulation Network Based on RNA-Binding Protein Genes in Lung Squamous Cell Carcinoma.
Zhao S; Liu Q; Li J; Hu C; Cao F; Ma W; Gao J
DNA Cell Biol; 2021 Dec; 40(12):1563-1583. PubMed ID: 34931870
[TBL] [Abstract][Full Text] [Related]
11. Identification of Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Li N; Wang J; Zhan X
Front Immunol; 2021; 12():752643. PubMed ID: 34887858
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D Repletion Reduces the Progression of Premalignant Squamous Lesions in the NTCU Lung Squamous Cell Carcinoma Mouse Model.
Mazzilli SA; Hershberger PA; Reid ME; Bogner PN; Atwood K; Trump DL; Johnson CS
Cancer Prev Res (Phila); 2015 Oct; 8(10):895-904. PubMed ID: 26276745
[TBL] [Abstract][Full Text] [Related]
13. Novel medium-term carcinogenesis model for lung squamous cell carcinoma induced by N-nitroso-tris-chloroethylurea in mice.
Tago Y; Yamano S; Wei M; Kakehashi A; Kitano M; Fujioka M; Ishii N; Wanibuchi H
Cancer Sci; 2013 Dec; 104(12):1560-6. PubMed ID: 24106881
[TBL] [Abstract][Full Text] [Related]
14. Immune Infiltration Landscape in Lung Squamous Cell Carcinoma Implications.
Zhao J; Bao W; Cai W
Biomed Res Int; 2020; 2020():5981870. PubMed ID: 33102584
[TBL] [Abstract][Full Text] [Related]
15. Specific Lung Squamous Cell Carcinoma Prognosis-Subtype Distinctions Based on DNA Methylation Patterns.
Huang G; Zhang J; Gong L; Liu D; Wang X; Chen Y; Guo S
Med Sci Monit; 2021 Mar; 27():e929524. PubMed ID: 33661858
[TBL] [Abstract][Full Text] [Related]
16. miR-30a-5p suppresses lung squamous cell carcinoma via ATG5 - mediated autophagy.
Yang J; Rao S; Cao R; Xiao S; Cui X; Ye L
Aging (Albany NY); 2021 Jul; 13(13):17462-17472. PubMed ID: 34253689
[TBL] [Abstract][Full Text] [Related]
17. PAK5 promotes the cell stemness ability by phosphorylating SOX2 in lung squamous cell carcinomas.
Bao Z; Ji W; Yang Y; Chen Z; Li Z; Wang K; Lu T; Yu Y; Xia W; Lu S
Exp Cell Res; 2020 Oct; 395(2):112187. PubMed ID: 32721391
[TBL] [Abstract][Full Text] [Related]
18. Novel mutational landscapes and expression signatures of lung squamous cell carcinoma.
Xiong D; Pan J; Yin Y; Jiang H; Szabo E; Lubet RA; Wang Y; You M
Oncotarget; 2018 Jan; 9(7):7424-7441. PubMed ID: 29484121
[TBL] [Abstract][Full Text] [Related]
19. LncRNA RP11-116G8.5 promotes the progression of lung squamous cell carcinoma through sponging miR-3150b-3p/miR-6870-5p to upregulate PHF12/FOXP4.
Li H; Zhao Q; Tang Z
Pathol Res Pract; 2021 Oct; 226():153566. PubMed ID: 34500373
[TBL] [Abstract][Full Text] [Related]
20. Factor XIIIA-expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking.
Porrello A; Leslie PL; Harrison EB; Gorentla BK; Kattula S; Ghosh SK; Azam SH; Holtzhausen A; Chao YL; Hayward MC; Waugh TA; Bae S; Godfrey V; Randell SH; Oderup C; Makowski L; Weiss J; Wilkerson MD; Hayes DN; Earp HS; Baldwin AS; Wolberg AS; Pecot CV
Nat Commun; 2018 May; 9(1):1988. PubMed ID: 29777108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
